1. New disease modifying therapies for two genetic childhood-onset neurometabolic disorders (metachromatic leucodystrophy and adrenoleucodystrophy)

   • Antonio Federico
   • Marianne de Visser

   Editorial 01 July 2021 Pages: 2603 - 2606

2. Virtual visits for chronic neurologic disorders during COVID-19 pandemic

   • Irene Rosellini
   • Marika Vianello
   • Domenico Marco Bonifati

   COVID-19 27 March 2021 Pages: 2607 - 2610

   

3. COVID-19-related refractory status epilepticus with the presence of SARS-CoV-2 (RNA) in the CSF: a case report

   • Sanaz Ahmadi Karvigh
   • Fahimeh Vahabizad
   • Mahnaz Montazeri

   COVID-19 15 April 2021 Pages: 2611 - 2614

   

4. Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage

   • Vahid Shaygannejad
   • Omid Mirmosayyeb
   • Mahsa Ghajarzadeh

   COVID-19 15 April 2021 Pages: 2615 - 2618

5. Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report

   • Marco Bozzali
   • Alberto Grassini
   • Leonardo Lopiano

   COVID-19 16 April 2021 Pages: 2619 - 2623

   

6. Subjective cognitive failures and their psychological correlates in a large Italian sample during quarantine/self-isolation for COVID-19

   • Gabriella Santangelo
   • Ivana Baldassarre
   • Simona Raimo

   COVID-19 Open access 29 April 2021 Pages: 2625 - 2635

   

7. Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic in Milan, Lombardy

   • Davide Pareyson
   • Chiara Pantaleoni
   • for the Besta-Telehealth Task Force

   COVID-19 30 April 2021 Pages: 2637 - 2644

8. The relationship between COVID-19’s severity and ischemic stroke: a systematic review and meta-analysis

   • Yue Lu
   • Jie-ji Zhao
   • Zhuan Xu

   COVID-19 05 May 2021 Pages: 2645 - 2651

   

9. Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment

   • Zahra Asefy
   • Sirus Hoseinnejhad
   • Zaker Ceferov

   Review Article 12 April 2021 Pages: 2653 - 2660

   

10. Efficacy and safety of general anesthesia deep brain stimulation for dystonia: an individual patient data meta-analysis of 341 cases

    • Jia-jing Wang
    • Han Tian
    • Peng Fu

    Review Article 14 April 2021 Pages: 2661 - 2671

    

11. New pharmacological and neuromodulation approaches for impulsive-compulsive behaviors in Parkinson’s disease

    • Giacomo Grassi
    • Giovanni Albani
    • Silvia Ramat

    Review Article 14 April 2021 Pages: 2673 - 2682

    

12. Primary headache research output and association with socioeconomic factors in Southeast Asia: a bibliometric analysis

    • Mia Patrice D. Dela Vega
    • Jeryl Ritzi T. Yu
    • Roland Dominic G. Jamora

    Review Article 20 April 2021 Pages: 2683 - 2693

    

13. Constraint-induced movement therapy protocols using the number of repetitions of task practice: a systematic review of feasibility and effects

    • Auwal Abdullahi
    • Sevim Acaroz Candan
    • Wim Saeys

    Review Article 22 April 2021 Pages: 2695 - 2703

    

14. Genetic polymorphisms in SCN2A are not associated with epilepsy risk and AEDs response: evidence from a meta-analysis

    • Ruiqing Yang
    • Ruiyi Qian
    • Xiutian Sima

    Review Article 29 April 2021 Pages: 2705 - 2711

    

15. Albumin therapy for acute ischemic stroke: a meta-analysis

    • Yanjie Huang
    • Zheng Xiao

    Review Article 04 May 2021 Pages: 2713 - 2719

    

16. Othello syndrome in Parkinson’s disease: a systematic review and report of a case series

    • Giovanna De Michele
    • Gianluigi Rosario Palmieri
    • Anna De Rosa

    Review Article Open access 12 May 2021 Pages: 2721 - 2729

    

17. Peripheral nervous system in multiple sclerosis—understanding the involvement via autonomic nervous system

    • Ivan Adamec
    • Magdalena Krbot Skorić
    • Mario Habek

    Review Article 25 May 2021 Pages: 2731 - 2736

    

18. A founder mutation in PEX12 among Egyptian patients in peroxisomal biogenesis disorder

    • Maha S. Zaki
    • Mahmoud Y. Issa
    • Joseph G. Gleeson

    Original Article 29 October 2020 Pages: 2737 - 2745

    

19. Role of LCF scale as an outcome prognostic index in patients with traumatic brain injury

    • Elena Rossato
    • Elisabetta Verzini
    • Silvia Bonadiman

    Original Article 29 October 2020 Pages: 2747 - 2752

    

20. Prevalence of cerebrovascular diseases that can cause hemorrhagic stroke in liver transplantation recipients: a 6-year comparative study with 24,681 healthy adults

    • Yeongu Chung
    • Seungjoo Lee
    • Wonhyoung Park

    Original Article 30 October 2020 Pages: 2753 - 2761

    

21. Does anodal trans-cranial direct current stimulation of the damaged primary motor cortex affects wrist flexor muscle spasticity and also activity of the wrist flexor and extensor muscles in patients with stroke?: a Randomized Clinical Trial

    • Sara Halakoo
    • Fatemeh Ehsani
    • Shapour Jaberzadeh

    Original Article 04 November 2020 Pages: 2763 - 2773

    

22. The impact of distinct cognitive dual-tasks on gait in Parkinson’s disease and the associations with the clinical features of Parkinson’s disease

    • Halil Onder
    • Ozge Ozyurek

    Original Article 04 November 2020 Pages: 2775 - 2783

23. Breaking the ice to improve motor outcomes in patients with chronic stroke: a retrospective clinical study on neuromodulation plus robotics

    • Antonino Naro
    • Luana Billeri
    • Rocco Salvatore Calabrò

    Original Article 06 November 2020 Pages: 2785 - 2793

    

24. Effect of whole-body vibration on freezing and flexibility in Parkinson’s disease—a pilot study

    • Andrea Dincher
    • Paula Becker
    • Georg Wydra

    Original Article Open access 07 November 2020 Pages: 2795 - 2801

    

25. The clinical utility of the cervical vestibular-evoked myogenic potential (cVEMP) in university-level athletes with concussion

    • Lilian Felipe
    • Jeremy A. Shelton

    Original Article 08 November 2020 Pages: 2803 - 2809

    

26. Adults with severe Japanese encephalitis: a retrospective analysis of 9 cases in Linyi, China

    • Qi Su
    • Zhong-Xiang Xie
    • Feng-Yuan Che

    Original Article 09 November 2020 Pages: 2811 - 2817

27. Whole-exome sequencing in patients with protein aggregate myopathies reveals causative mutations associated with novel atypical phenotypes

    • Marcin M. Machnicki
    • Valeria Guglielmi
    • Gaetano Vattemi

    Original Article Open access 10 November 2020 Pages: 2819 - 2827

    

28. Effect of prediabetes on asprin or clopidogrel resistance in patients with recent ischemic stroke/TIA

    • Weili Jia
    • Qian Jia
    • Yongjun Wang

    Original Article 11 November 2020 Pages: 2829 - 2835

29. Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results

    • Ruggero Capra
    • Vincenzo Brescia Morra
    • on behalf of the WANT Investigators

    Original Article 17 November 2020 Pages: 2837 - 2845

    

30. The impact of lymphocytosis and CD4/CD8 ratio on the anti-JCV antibody index and clinical data in patients treated with natalizumab

    • Jan Kolcava
    • Monika Hulova
    • Pavel Stourac

    Original Article 17 November 2020 Pages: 2847 - 2853

    

31. The significance of myositis autoantibodies in idiopathic inflammatory myopathy concomitant with interstitial lung disease

    • Hung-Ling Huang
    • Wen-Chih Lin
    • Yuan-Ting Sun

    Original Article 19 November 2020 Pages: 2855 - 2864

    

32. Do serum GDNF levels correlate with severity of Alzheimer’s disease?

    • Maryam Sharif
    • Maryam Noroozian
    • Farshad Hashemian

    Original Article 19 November 2020 Pages: 2865 - 2872

    

33. The increase of neuropathic symptoms in diabetic patients is related with osteopenia

    • Elif Börekci
    • Adem Kara
    • Yalçın Aral

    Original Article 20 November 2020 Pages: 2873 - 2880

    

34. Lipid profiles and their potential inflammatory effects in anti-N-methyl-D-aspartate receptor encephalitis

    • Fei Liu
    • Baojie Wang
    • Shougang Guo

    Original Article 20 November 2020 Pages: 2881 - 2890

35. Assessment of mental health, knowledge, and attitude of patients with multiple sclerosis and neuromyelitis optica spectrum disorder in response to 2019 novel coronavirus

    • Vahid Shaygannejad
    • Alireza Afshari-Safavi
    • Boshra Hatef

    Original Article 20 November 2020 Pages: 2891 - 2901

36. Validation of the Italian version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19

    • Antonio Carotenuto
    • Laura De Giglio
    • Roberta Lanzillo

    Original Article 21 November 2020 Pages: 2903 - 2910

37. GLP-1R activation alters performance in cognitive tasks in a sex-dependent manner

    • Taylor S. Trammell
    • Natalie L. Henderson
    • Devon L. Graham

    Original Article 22 November 2020 Pages: 2911 - 2919

    

38. Association between freezing of gait and bone mineral density in patients with Parkinson’s disease

    • Seong-Min Choi
    • Soo Hyun Cho
    • Byeong C. Kim

    Original Article 23 November 2020 Pages: 2921 - 2925

39. Cross-cultural adaptation and psychometric properties of the Turkish version of the Manual Ability Measure-36 (MAM-36) in people with multiple sclerosis

    • Ozge Ertekin
    • Turhan Kahraman
    • Serkan Ozakbas

    Original Article 24 November 2020 Pages: 2927 - 2936

40. Different functional connectivity modes of the right fronto-insular cortex in akinetic-rigid and tremor-dominant Parkinson’s disease

    • Juan Wang
    • Yalian Shen
    • Oumei Cheng

    Original Article 24 November 2020 Pages: 2937 - 2946

    

41. Neuroimaging in idiopathic adult-onset focal dystonia

    • Giovanni Fabbrini
    • Antonella Conte
    • The Italian Dystonia Registry participants

    Original Article 03 January 2021 Pages: 2947 - 2950

    

42. Association between subjective autonomic dysfunction and fatigue in Parkinson’s disease in southern Chinese

    • Zongbo Zhao
    • Hui Liu
    • Nianxing You

    Original Article 05 April 2021 Pages: 2951 - 2954

43. Adult polyglucosan body disease—an atypical compound heterozygous with a novel GBE1 mutation

    • Andreia Carvalho
    • Joana Nunes
    • Pedro Barros

    Brief Communication 31 January 2021 Pages: 2955 - 2959

    

44. Device-aided therapies for advanced Parkinson disease: insights from an international survey

    • Luca Marsili
    • Matteo Bologna
    • Carlo Colosimo

    Brief Communication 06 February 2021 Pages: 2961 - 2964

    

45. Migraine and handedness

    • Giovanni Battista La Pegna
    • Giuseppe Quatrosi
    • Vincenzo Raieli

    Brief Communication 06 February 2021 Pages: 2965 - 2968

46. A novel SACS p.Pro4154GlnfsTer20 mutation in a family with autosomal recessive spastic ataxia of Charlevoix-Saguenay

    • Bedia Samanci
    • Ebru Erzurumluoglu Gokalp
    • Hasmet A. Hanagasi

    Brief Communication 09 February 2021 Pages: 2969 - 2973

    

47. Homozygous ADCY5 mutation causes early-onset movement disorder with severe intellectual disability

    • Nobuhiko Okamoto
    • Fuyuki Miya
    • Kenjiro Kosaki

    Brief Communication 11 March 2021 Pages: 2975 - 2978

    

48. Clinical characteristics of MOG antibody disease: two case reports

    • Yujia Guan
    • Zunwei Zhang
    • Hui Deng

    Letter to the Editor Open access 10 February 2021 Pages: 2979 - 2985

    

49. Deep brain stimulation in Fragile X syndrome with tardive dystonia

    • Francesco Bove
    • Carla Piano
    • Tommaso Tufo

    Letter to the Editor 12 February 2021 Pages: 2987 - 2989

    

50. Delayed recurrence of neonatal HSV-2 encephalitis after 21 years, complicated by ischemic stroke: a case report

    • Muhammad Qasim
    • César E. Escamilla-Ocañas
    • Chethan P. Venkatasubba Rao

    Letter to the Editor 27 February 2021 Pages: 2991 - 2994